The results showed that, compared with the control group, the levels of α‐SMA, vimentin, and N‐cadherin were increased, and the protein levels of E‐cadherin in the CKD group were significantly reduced (Figure 1E,F). The gene discussed is ACTA1; the disease is chronic kidney disease.